Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models

par Raifu, AO, Arbyn, M
Publié 2009

Translational Mini-Review Series on Vaccines: Monitoring of human papillomavirus vaccination

par Dillner, J, Arbyn, M, Dillner, L
Publié 2007

Monitoring of human papillomavirus vaccination

par Dillner, J, Arbyn, M, Unger, E, Dillner, L
Publié 2011

Efficacy of strategies to increase participation in cervical cancer screening: GPs offering self-sampling kits for HPV testing versus recommendations to have a pap smear taken - A...

par Peeters, E., Cornet, K., Devroey, D., Arbyn, M.
Publié dans Papillomavirus Res (2020)

Use of HC2 to triage women with borderline and mild dyskaryosis in the UK

par Arbyn, M, Roelens, J, Martin-Hirsch, P, Leeson, S, Wentzensen, N
Publié 2011

Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework

par Cuschieri, K., Geraets, D. T., Moore, C., Quint, W., Duvall, E., Arbyn, M.
Publié dans J Clin Microbiol (2015)

Corrigendum to “Efficacy of strategies to increase participation in cervical cancer screening: GPs offering self-sampling kits for HPV testing versus recommendations to have a pap...

par Peeters, E., Cornet, K., Cammu, H., Verhoeven, V., Devroey, D., Arbyn, M.
Publié dans Papillomavirus Res (2020)

A44 Complete HPV genomes from cervical samples using next-generation sequencing in Luxembourg

par Latsuzbaia, A, Tapp, J, Ragimbeau, C, Fischer, M, Weyers, S, Arbyn, M, Mossong, J
Publié dans Virus Evol (2018)

Cervical cancer screening programmes and policies in 18 European countries

par Anttila, A, Ronco, G, Clifford, G, Bray, F, Hakama, M, Arbyn, M, Weiderpass, E
Publié 2004

p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis

par Tsoumpou, I, Arbyn, M, Kyrgiou, M, Wentzensen, N, Koliopoulos, G, Martin-Hirsch, P, Paraskevaidis, E
Publié 2009

Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis

par Arbyn, M, Kyrgiou, M, Simoens, C, Raifu, A O, Koliopoulos, G, Martin-Hirsch, P, Prendiville, W, Paraskevaidis, E
Publié 2008

Clinical Validation of a Type-Specific Real-Time Quantitative Human Papillomavirus PCR against the Performance of Hybrid Capture 2 for the Purpose of Cervical Cancer Screening

par Depuydt, C. E., Benoy, I. H., Beert, J. F. A., Criel, A. M., Bogers, J. J., Arbyn, M.
Publié 2012

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document

par Arbyn, M., Anttila, A., Jordan, J., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., von Karsa, L.
Publié 2010

Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women

par Depuydt, C E, Vereecken, A J, Salembier, G M, Vanbrabant, A S, Boels, L A, van Herck, E, Arbyn, M, Segers, K, Bogers, J J
Publié 2003

Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel

par Polman, N. J., Oštrbenk, A., Xu, L., Snijders, P. J. F., Meijer, C. J. L. M., Poljak, M., Heideman, D. A. M., Arbyn, M.
Publié dans J Clin Microbiol (2017)

Clinical Evaluation of a GP5+/6+-Based Luminex Assay Having Full High-Risk Human Papillomavirus Genotyping Capability and an Internal Control

par Geraets, D. T., Cuschieri, K., de Koning, M. N. C., van Doorn, L. J., Snijders, P. J. F., Meijer, C. J. L. M., Quint, W. G. V., Arbyn, M.
Publié dans J Clin Microbiol (2014)

Correction for Geraets et al., Clinical Evaluation of a GP5+/6+-Based Luminex Assay Having Full High-Risk Human Papillomavirus Genotyping Capability and an Internal Control

par Geraets, D. T., Cuschieri, K., de Koning, M. N. C., van Doorn, L. J., Snijders, P. J. F., Meijer, C. J. L. M., Quint, W. G. V., Arbyn, M.
Publié dans J Clin Microbiol (2016)

Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of the literature

par Kalliala, I., Athanasiou, A., Veroniki, A.A., Salanti, G., Efthimiou, O., Raftis, N., Bowden, S., Paraskevaidi, M., Aro, K., Arbyn, M., Bennett, P., Nieminen, P., Paraskevaidis, E., Kyrgiou, M.
Publié dans Ann Oncol (2020)

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women of 30 years and older

par Meijer, C.J.L.M., Berkhof, J., Castle, P.E., Hesselink, A., Franco, E.L., Ronco, G, Arbyn, M., Bosch, FX., Cuzick, J., Dillner, J., Heideman, D.A.M., Snijders, P.J.F.
Publié 2009

A comprehensive evaluation of the accuracy of cervical pre-cancer detection methods in a high-risk area in East Congo

par Hovland, S, Arbyn, M, Lie, A K, Ryd, W, Borge, B, Berle, E J, Skomedal, H, Kadima, T M, Kyembwa, L, Billay, E M, Mukwege, D, Chirimwami, R B, Mvula, T M, Snijders, P J, Meijer, C J L M, Karlsen, F
Publié 2010